Market Place
Sourcing Support
All News #Library
Biotech
DBV Technologies Files 2025 Form 10-K And Registration Document
26 Mar 2026 //
GLOBENEWSWIRE
DBV Technologies Unveils 2025 Financials And Business Progress
26 Mar 2026 //
GLOBENEWSWIRE
DBV Technologies Enters CAC Mid 60 & SBF 120 Indices In Euronext
24 Mar 2026 //
GLOBENEWSWIRE
DBV Highlights VITESSE Phase 3 Data at 2026 AAAAI Meeting
28 Feb 2026 //
GLOBENEWSWIRE
DBV to Present Phase 3 Viaskin Peanut Patch Data at AAAAI 2026
10 Feb 2026 //
GLOBENEWSWIRE
DBV Technologies Joins Guggenheim Biotech Summit
09 Feb 2026 //
GLOBENEWSWIRE
DBV Technologies Raises €166.7M From ABSA And BS Warrants
16 Jan 2026 //
GLOBENEWSWIRE
DBV Announces Positive Phase 3 VIASKIN Peanut Patch Results
16 Dec 2025 //
GLOBENEWSWIRE
DBV Technologies To Attend Guggenheim Healthcare Conference
04 Nov 2025 //
GLOBENEWSWIRE
DBV Technologies Names Kevin Trapp Chief Commercial Officer
03 Nov 2025 //
GLOBENEWSWIRE
DBV Technologies Reports Third Quarter 2025 Financial Results
28 Oct 2025 //
GLOBENEWSWIRE
DBV Technologies secures $306.9M for Viaskin Peanut Patch launch
27 Mar 2025 //
GLOBENEWSWIRE
DBV Technologies reaches FDA agreement on Viaskin Peanut Patch
24 Mar 2025 //
GLOBENEWSWIRE
DBV Technologies Reports Q3 2024 Financial Results
06 Nov 2024 //
GLOBENEWSWIRE
DBV Announces Positive Regulatory Updates For Viaskin® Peanut Patch
22 Oct 2024 //
GLOBENEWSWIRE
DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1-3 Y
19 Apr 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.